Rail Vision Ltd Ordinary Share (RVSN) had the highest return in January 2024 by a US stock with a market cap of <= $2B, returning 855.1%.

ASSET	MONTH	% RETURN
Rail Vision Ltd Ordinary Share (RVSN)	January 2024	855.13%
Zivo Bioscience (ZIVO)	January 2024	504.36%
Corbus Pharmaceuticals (CRBP)	January 2024	340.77%
Phunware (PHUN)	January 2024	276.47%
CCSC Technology International Holdings Limited Ordinary Shares (CCTG)	January 2024	268.52%
Swvl (SWVL)	January 2024	200%
CalciMedica, Inc Common Stock (CALC)	January 2024	153.06%
Cadrenal Therapeutics, Inc Common Stock (CVKD)	January 2024	144.16%
OneMedNet (ONMD)	January 2024	140.76%
Nyxoah (NYXH)	January 2024	133.19%
QuantaSing Group Limited American Depositary Shares (QSG)	January 2024	127.65%
Here (HERE)	January 2024	127.65%
Mega Matrix (MPU)	January 2024	127.34%
FibroGen (FGEN)	January 2024	127.22%
Inhibikase Therapeutics (IKT)	January 2024	126.73%
Alaunos Therapeutics (TCRT)	January 2024	124.2%
Exodus Movement (EXOD)	January 2024	119.57%
FiEE (FIEE)	January 2024	115.79%
Pyxis Oncology (PYXS)	January 2024	112.85%
Perspective Therapeutics (CATX)	January 2024	102.5%
Connexa Sports Technologies (YYAI)	January 2024	97.04%
Akso Health Group ADR (AHG)	January 2024	95.24%
Fitell Corporation Ordinary Shares (FTEL)	January 2024	90.13%
ADC Therapeutics (ADCT)	January 2024	87.95%
Adagene (ADAG)	January 2024	86.73%